NCT01533506View on ClinicalTrials.gov

Stiripentol in Dravet Syndrome

NO_LONGER_AVAILABLEEXPANDED_ACCESS
Timeline

Start Date

February 29, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Dravet Syndrome
Interventions
DRUG

stiripentol

Stiripentol up to 30 mg/kg/day to control seizures

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT01533506 - Stiripentol in Dravet Syndrome | Biotech Hunter | Biotech Hunter